Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2.06M
-
Shares change
-
+1.17M
-
Total reported value, excl. options
-
$5.72M
-
Value change
-
+$3.24M
-
Number of buys
-
14
-
Number of sells
-
-4
-
Price
-
$2.78
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q2 2024
29 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q2 2024.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.06M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.02M shares), Invenomic Capital Management LP (514K shares), GEODE CAPITAL MANAGEMENT, LLC (115K shares), VANGUARD GROUP INC (93.6K shares), GenTrust, LLC (60K shares), Raymond James Financial Services Advisors, Inc. (48.8K shares), STATE STREET CORP (39.3K shares), BlackRock Inc. (27.4K shares), Welch Group, LLC (24K shares), and MORGAN STANLEY (23K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.